Safanad is a leading real estate and private equity investment firm that invests largely in the United States and Europe. It primarily focuses on value-added and opportunistic real estate investments as well as private equity businesses in the healthcare and education sectors, typically backed by significant real estate assets. Since its establishment in 2009, Safanad has completed more than 40 transactions totaling $10 billion.
Safanad targets opportunities to deploy capital below replacement value and where its investment thesis is supported by constrained short-to-medium term supply and strong long-term demand.
Safanad focuses on businesses with stable revenue and earnings, and where it can identify an opportunity to create additional value through a buy-and-build strategy.